82576-100 : Rezdiffra 100 mg Oral Tablet, Coated


NDC: 82576-100
Labeler: Madrigal Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Rezdiffra
Dosage Form: Oral Tablet, Coated
Application #: NDA217785
Rev. Date: 


NDC Package Codes:

  • 82576-100-30: 30 TABLET, COATED IN 1 BOTTLE (82576‑100‑30)
  • 82576-100-90: 90 TABLET, COATED IN 1 BOTTLE (82576‑100‑90)

Active Ingredients:

  • Resmetirom

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
  • Thyroid Hormone Receptor beta Agonist [EPC]
  • Thyroid Hormone Receptor beta Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 82576-060 Rezdiffra 60 mg Oral Tablet, Coated by Madrigal Pharmaceuticals, Inc.
  • 82576-080 Rezdiffra 80 mg Oral Tablet, Coated by Madrigal Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 82576-100 QR Code

< Prev: 82576-080Next: 82577-967 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.